Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer… Read More »The Ageing Soma, Screening and All-Cause Mortality
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and… Read More »Five minutes with: Dr Mona Saraiya
In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the… Read More »Finding the optimal HPV test for primary screening and triage in Latin America
The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very… Read More »Over 99.5% of young women survive following a diagnosis of IA cervical cancer
In this post, we interview Rebecca Fitzgerald, chief investigator for the BEST3 trial. Her work at the MRC Cancer Unit focuses on the early detection… Read More »Best of BEST3: An interview with Rebecca Fitzgerald, Chief Investigator
In this post, we interview Irene Debiram-Beecham, clinical coordinator for the BEST3 trial. Irene is a Senior Research Sister in Professor Rebecca’s Fitzgerald’s group and… Read More »Best of BEST3: An interview with Irene Debiram-Beecham, clinical coordinator
A friend of mine in her late 40s has just been diagnosed with breast cancer. Fortunately, she spotted it early and it sounds as if… Read More »Breast screening for women in their 40s – what are we waiting for?
In this post Rose Brade, International Policy Advisor at Cancer Research UK provides her personal experiences with vaccine hesitancy and the implications for cervical cancer… Read More »Vaccine hesitancy and disease prevention – It’s not just coronavirus which stands to lose
In this blog, we interview Beth Muldrew, Clinical Project Manager for the BEST3 trial. Beth successfully managed the project from start-up to conclusion, working across… Read More »Best of BEST3: a Q&A with Beth Muldrew, Clinical Project Manager
The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the… Read More »Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge
